) The Translational Oncology Program consists of 49 Members, representing total peer-reviewed funding of $5,642,092 in annual direct costs. During the last year, its Members produced 140 cancer-relevant, peer-reviewed publications, 26% of which were intra- and inter-programmatic collaborations. Members are focused on testing the clinical validity and applicability of observations emerging from basic biological laboratories and on understanding the underlying molecular and cellular mechanisms that determine the pathogenesis, prognosis and therapeutic susceptibility of the tumor. We recognize from recent direct experience that the current strong trends toward specialization in medical practice and changes in healthcare organization in California and elsewhere can constitute a challenge to academic medicine and research. We nevertheless believe that its momentum can also be harnessed to promote expertise and quality, if one adapts speedily, flexib ly and wisely. Accordingly, we have encouraged the development of interactive clinical organ- and/or research-specific focus groups around which basic and population scientists can assemble for mutual interest and benefit. These are thriving and intellectually productive, judged by objective measures such as discoveries, publications and peer reviewed grant support. The Translational Oncology Program consists of several well-established clinical focus groups in the specific areas of breast cancer, leukemia/lymphoma, stem cell transplantation, melanoma, head and neck cancer, and pediatric oncology, and is actively implementing measures which are assisting other focus groups to realize full potential. The many strong laboratory teams and powerful analytical disciplines, such as gene therapy and molecular pathology converging here with clinical medicine are, therefore, standing on the brink of very productive and stimulating times. Together with the interactive potential of the new sh ared resources assembling in this Center, our clinical research is expected to be powerfully fruitful in the practical application of new discoveries during the next funding cycle.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023100-17
Application #
6316527
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2000-05-26
Project End
2001-04-30
Budget Start
Budget End
Support Year
17
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Jiang, Qingfei; Jamieson, Catriona (2018) BET'ing on Dual JAK/BET Inhibition as a Therapeutic Strategy for Myeloproliferative Neoplasms. Cancer Cell 33:3-5
Ramirez, Oscar; Aristizabal, Paula; Zaidi, Alia et al. (2018) Implementing a Childhood Cancer Outcomes Surveillance System Within a Population-Based Cancer Registry. J Glob Oncol :1-11
Liu, Liang; Yang, Lin; Yan, Wei et al. (2018) Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis. Clin Cancer Res 24:2370-2382
Lwin, Thinzar M; Murakami, Takashi; Miyake, Kentaro et al. (2018) Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore. Ann Surg Oncol 25:1079-1085
Singh, Siddharth; Loomba, Rohit (2018) Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases. Hepatology 67:13-15
Hartman, Sheri J; Nelson, Sandahl H; Myers, Emily et al. (2018) Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study. Cancer 124:192-202
Hoffmann, Hanne M; Gong, Ping; Tamrazian, Anika et al. (2018) Transcriptional interaction between cFOS and the homeodomain-binding transcription factor VAX1 on the GnRH promoter controls Gnrh1 expression levels in a GnRH neuron maturation specific manner. Mol Cell Endocrinol 461:143-154
Liu, Xuxiang; Cao, Minghui; Palomares, Melanie et al. (2018) Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts. Breast Cancer Res 20:127
Huang, Justin K; Carlin, Daniel E; Yu, Michael Ku et al. (2018) Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. Cell Syst 6:484-495.e5
Kalyanaraman, Hema; Schwaerzer, Gerburg; Ramdani, Ghania et al. (2018) Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. Diabetes 67:607-623

Showing the most recent 10 out of 862 publications